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Figure 1 The 5 stages of Biofilm Formation and Development, Schematic and corresponding 
electron micrographs. 1- initial attachment, 2-irreversible attachment, 3- maturation 1, 4-
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TABLE	1	KEIO	COLLECTION	KNOCKOUT	MUTANTS	USED	IN	RESEARCH	PROJECT	
Strain	 Chromosomal	marker	 Deletion	 Gene	function	








Jw0531-2	 ∆emrE750::kan	 emrE	 A	proton	linked	multi	drug	
transporter	belonging	to	the	
SMR	family	(62,	124)	












































Ampicillin	 Ethanol	 16	 16	
Rifampicin	 DMSO		 64	 64	
Chloramphenicol		 Ethanol	 128	 128	











Capsaicin	 Ethanol	100%	 2	 10	
PAβN	 Ethanol	100%	 2	 10	
CCCP	 DMSO	100%	 2	 10	
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Wild	type	 TolC	 AcrB	 AcrA	 EmrA	
	 15min	 6hr		 15min		 6hr	 15min		 6hr	 15min		 6hr	 15min		 6hr	
	
Control	
	 5.43*	 5.73*	 5.61*	 4.68*	 5.19*	 6.15*	 5.50*	 6.51*	 6.19	 6.65*	
CCCP	
	 0.12	 1.07	 0.45	 2.25	 -0.09	 0.96	 0.39	 0.88	 0.05	 0.72	
PAβN		
	 0.16	 1.80	 1.08	 2.85	 0.05	 1.08	 0.58	 1.03	 0.85	 1.81	
Capsaicin	
	 0.20	 0.21	 0.56	 0.66	 0.12	 1.12	 0.17	 0.31	 0.25	 1.13	
*=	Actual	count		
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Wild	type	 tolC	 acrB	 acrA	 emrA	
Control	
	
5.73*	 4.68*	 6.15*	 6.51*	 6.65*	
CCCP	
	
1.07	 2.25	 0.96	 0.88	 0.72	
PAβN		
	
1.80	 2.85	 1.08	 1.03	 1.81	
Capsaicin	
	
0.21	 0.66	 1.12	 0.31	 1.13	
Ampicillin	
	
0.96	 0.65	 0.53	 0.82	 1.36	
Ampicillin	&	CCCP	
	
2.55	 3.14	 1.55	 1.21	 1.75	
Ampicillin	&	PAβN	
	
3.03	 4.68t	 6.15t	 1.98	 6.65t	
Ampicillin	&	Capsaicin	
	
3.03	 4.68t	 1.51	 0.57	 1.47	
Rifampicin	
	
0.83	 1.81	 1.30	 0.57	 1.36	
Rifampicin	&	CCCP	
	
1.68	 2.38	 1.63	 0.88	 1.61	
Rifampicin	&	PAβN	
	
3.03	 2.85	 6.15	 1.32	 1.95	
Rifampicin	&	
Capsaicin	
2.55	 2.67	 1.09	 0.60	 1.54	
Chloramphenicol	
	
0.74	 2.31	 0.41	 0.78	 1.30	
Chloramphenicol		&	
CCCP	
3.03	 4.68t	 2.32	 1.29	 2.65	
Chloramphenicol	&	
PAβN	
5.73	 4.68t	 6.15t	 6.51t	 6.65t	
Chloramphenicol	&	
Capsaicin	
3.03	 4.68t	 2.63	 1.98	 2.05	
Nalidixic	Acid	
	
2.55	 0.50	 0.76	 0.47	 0.78	
Nalidixic	Acid	&	CCCP	
	
1.88	 4.68t	 2.15	 1.29	 2.05	
Nalidixic	Acid	&	PAβN	
	
2.55	 4.68t	 6.15t	 2.98	 6.65t	
Nalidixic	Acid	&	
Capsaicin	
1.26	 2.67	 2.63	 1.94	 2.01	
*	=	Actual	counts	t	=	total	reduction,	actual	count	is	0	below	limit	of	detection	
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tolC	 acrB	 acrA	 emrA	 emrB	 emrE	 ompR	
Control	
	
5.43	 5.61	 5.19	 5.50	 6.19	 5.01	 4.87	 5.43	
CCCP	
	
5.30	 5.15	 5.28	 5.11	 6.13	 4.78	 4.70	 5.60	
PAβN		
	
5.26	 4.53	 5.14	 4.92	 5.34	 4.58	 4.43	 5.14	
Capsaicin	
	
5.22	 5.05	 5.07	 5.33	 5.94	 3.75	 4.56	 5.40	
Ampicillin	
	
5.50	 5.47	 5.60	 5.62	 6.28	 5.05	 4.48	 5.75	
Ampicillin	&		
CCCP	
5.46	 5.47	 5.51	 5.66	 6.21	 5.30	 4.22	 5.46	
Ampicillin	&		
PAβN	
5.62	 5.60	 5.51	 5.57	 6.10	 5.31	 4.30	 5.46	
Ampicillin	&		
Capsaicin	
5.39	 5.45	 5.53	 5.58	 6.26	 5.32	 4.12	 5.63	
Rifampicin	
	
5.59	 5.37	 5.58	 5.56	 5.97	 5.06	 4.43	 5.74	
Rifampicin	&		
CCCP	
5.44	 5.36	 5.62	 5.54	 6.24	 5.44	 3.52	 5.83	
Rifampicin	&		
PAβN	
5.31	 4.33	 5.55	 5.55	 6.40	 5.34	 4.00	 5.56	
Rifampicin	&		
Capsaicin	
5.50	 5.13	 5.53	 5.48	 6.36	 5.37	 4.00	 5.69	
Chloramphenicol	
	
5.35	 5.45	 5.67	 5.55	 6.51	 5.14	 4.30	 5.81	
Chloramphenicol		&		
CCCP	
5.34	 5.45	 5.63	 5.46	 6.43	 5.46	 4.60	 5.91	
Chloramphenicol	&		
PAβN	
5.40	 5.42	 5.65	 5.59	 6.54	 5.47	 4.60	 5.85	
Chloramphenicol	&		
Capsaicin	
5.75	 5.31	 5.57	 5.54	 6.47	 5.43	 4.60	 5.58	
Nalidixic	Acid	
	
5.41	 5.48	 5.64	 5.63	 6.63	 4.73	 4.78	 5.93	
Nalidixic	Acid	&		
CCCP	
5.69	 5.27	 5.75	 5.44	 6.43	 5.38	 4.85	 5.75	
Nalidixic	Acid	&		
PAβN	
5.55	 5.18	 5.69	 5.55	 6.59	 5.35	 4.43	 5.63	
Nalidixic	Acid	&		
Capsaicin	
5.68	 5.53	 5.62	 5.53	 6.45	 5.19	 4.64	 5.96	
Gemma	Deakin	17117500		







































































































































































































































































































































































































































































































113	|	P a g e 	
143.	 Bohnert	JA,	Kern	WV.	Selected	arylpiperazines	are	capable	of	reversing	multidrug	resistance	
in	Escherichia	coli	overexpressing	RND	efflux	pumps.	Antimicrobial	agents	and	chemotherapy.	
2005;49(2):849-52.	
		
